急性冠状动脉综合征和卡特草药安非他命使用:一个观察报告
Waleed M Ali1, K F Al Habib, Ahmed Al-Motarreb
1Department of Cardiology, Hamad Medical Corp, Qatar.
Circulation
|December 14, 2011
概括
卡特与急性冠状动脉综合征患者的病情恶化有关,包括死亡和中风风险更高. 在 khat 上的教育.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 卡特 (Catha edulis) 是一种具有类似安非他命效果的兴奋剂植物.
- 卡特的使用在非洲之角和阿拉伯半岛普遍存在.
- 卡特被怀疑会诱导冠状动脉.
研究的目的:
- 为了评估急性冠状动脉综合征 (ACS) 患者的临床特征和结果,这些患者食卡特.
- 为了确定可口是否是心血管不良事件的独立风险因素.
主要方法:
- 分析了来自第二个海湾急性冠状动脉事件注册表 (Gulf RACE-2) 的数据.
- 在7999名ACS患者中,卡特者与非者之间的临床特征和结果的比较.
- 根据患者基线变异性的统计调整.
主要成果:
- 百分之十九的ACS患者是食者.
- 吃卡特的人年龄较大,男性程度较高,心率较高和基利普类.
- 吃卡特的人有死亡风险增加,复发性缺血,心脏性休克,心室节律失常和中风.
- 是死亡,复发性缺血,心力衰竭和中风的独立风险因素.
结论:
- 在ACS患者中,口与更糟糕的住院结果有关.
- 对于食者来说,不良结果持续到事件发生后的一年.
- 提高对卡特心血管风险的认识至关重要.
更多相关视频
相关概念视频
Adrenergic Agonists: Indirect-Acting Agents
2.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.8K
Adrenergic Agonists: Mixed-Action Agents
1.7K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.7K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.5K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.5K
Stimulants
1.4K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.4K
Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495


